Beverly A. Leslie

1.3k total citations
24 papers, 1.1k citations indexed

About

Beverly A. Leslie is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Beverly A. Leslie has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Beverly A. Leslie's work include Blood Coagulation and Thrombosis Mechanisms (19 papers), Blood properties and coagulation (17 papers) and Platelet Disorders and Treatments (10 papers). Beverly A. Leslie is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (19 papers), Blood properties and coagulation (17 papers) and Platelet Disorders and Treatments (10 papers). Beverly A. Leslie collaborates with scholars based in Canada, Germany and United States. Beverly A. Leslie's co-authors include Jeffrey I. Weitz, James C. Fredenburgh, Alan R. Stafford, Monika Hudoba, David A. Weitz, Stefan Münster, Louise Jawerth, Ben Fabry, Jeffrey S. Ginsberg and Trang Vu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Beverly A. Leslie

24 papers receiving 1.1k citations

Peers

Beverly A. Leslie
John W. Weisel United States
RR Hantgan United States
Richard J. Travers United States
VJ Marder United States
Pierre F. Neuenschwander United States
David A. Meh United States
Reginald Tran United States
Kevin R. Siebenlist United States
Irina N. Chernysh United States
Gregory A. Hair United States
John W. Weisel United States
Beverly A. Leslie
Citations per year, relative to Beverly A. Leslie Beverly A. Leslie (= 1×) peers John W. Weisel

Countries citing papers authored by Beverly A. Leslie

Since Specialization
Citations

This map shows the geographic impact of Beverly A. Leslie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Leslie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Leslie more than expected).

Fields of papers citing papers by Beverly A. Leslie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Leslie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Leslie. The network helps show where Beverly A. Leslie may publish in the future.

Co-authorship network of co-authors of Beverly A. Leslie

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Leslie. A scholar is included among the top collaborators of Beverly A. Leslie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Leslie. Beverly A. Leslie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeh, Calvin H., Brian Dale, Beverly A. Leslie, et al.. (2018). Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation. SHILAP Revista de lepidopterología. 2(2). e190–e201. 18 indexed citations
2.
Yeh, Calvin H., Alan R. Stafford, Beverly A. Leslie, James C. Fredenburgh, & Jeffrey I. Weitz. (2016). Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function. PLoS ONE. 11(6). e0157471–e0157471. 15 indexed citations
3.
Xia, Jing, Huayin Wu, Alan R. Stafford, et al.. (2015). Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure. Thrombosis and Haemostasis. 115(3). 533–542. 33 indexed citations
4.
Vu, Trang, Beverly A. Leslie, Alan R. Stafford, et al.. (2015). Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway. Thrombosis and Haemostasis. 115(1). 89–98. 43 indexed citations
5.
Vu, Trang, Ji Zhou, Beverly A. Leslie, et al.. (2015). Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood. 125(17). 2712–2719. 44 indexed citations
6.
Stafford, Alan R., Beverly A. Leslie, Paul Y. Kim, et al.. (2015). Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation. Thrombosis and Haemostasis. 113(6). 1278–1288. 18 indexed citations
7.
Kim, Paul Y., Trang Vu, Beverly A. Leslie, et al.. (2014). Reduced Plasminogen Binding and Delayed Activation Render γ′-Fibrin More Resistant to Lysis than γA-Fibrin. Journal of Biological Chemistry. 289(40). 27494–27503. 8 indexed citations
8.
Fredenburgh, James C., Beverly A. Leslie, Alan R. Stafford, et al.. (2013). Zn2+ Mediates High Affinity Binding of Heparin to the αC Domain of Fibrinogen. Journal of Biological Chemistry. 288(41). 29394–29402. 23 indexed citations
9.
Vu, Trang, Alan R. Stafford, Beverly A. Leslie, et al.. (2011). Histidine-rich Glycoprotein Binds Fibrin(ogen) with High Affinity and Competes with Thrombin for Binding to the γ′-Chain. Journal of Biological Chemistry. 286(35). 30314–30323. 31 indexed citations
10.
Stafford, Alan R., Jonathan W. Yau, Beverly A. Leslie, et al.. (2011). Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation. Blood. 117(15). 4134–4141. 53 indexed citations
11.
Stafford, Alan R., et al.. (2009). Long Range Communication between Exosites 1 and 2 Modulates Thrombin Function. Journal of Biological Chemistry. 284(38). 25620–25629. 69 indexed citations
12.
Fredenburgh, James C., Alan R. Stafford, Beverly A. Leslie, & Jeffrey I. Weitz. (2007). Bivalent Binding to γA/γ′-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex. Journal of Biological Chemistry. 283(5). 2470–2477. 54 indexed citations
13.
Chan, Howard H.W., Alan R. Stafford, Beverly A. Leslie, James C. Fredenburgh, & Jeffrey I. Weitz. (2007). Zinc Enhances the Protection of Fibrin-Bound Thrombin from Antithro Inhibition.. Blood. 110(11). 2691–2691. 1 indexed citations
14.
Stewart, R. J. C., James C. Fredenburgh, Beverly A. Leslie, et al.. (2000). Identification of the Mechanism Responsible for the Increased Fibrin Specificity of TNK-Tissue Plasminogen Activator Relative to Tissue Plasminogen Activator. Journal of Biological Chemistry. 275(14). 10112–10120. 45 indexed citations
15.
16.
Weitz, Jeffrey I., Beverly A. Leslie, J. Hirsh, & Petr Klement. (1993). Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.. Journal of Clinical Investigation. 91(4). 1343–1350. 39 indexed citations
17.
Weitz, Jeffrey I., Beverly A. Leslie, & Jeffrey S. Ginsberg. (1991). Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.. Journal of Clinical Investigation. 87(3). 1082–1090. 65 indexed citations
18.
Weitz, Jeffrey I., Jacob Kuint, Beverly A. Leslie, & Jack Hirsh. (1991). Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis. Thrombosis and Haemostasis. 65(5). 541–544. 8 indexed citations
19.
Weitz, Jeffrey I. & Beverly A. Leslie. (1990). Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.. Journal of Clinical Investigation. 86(1). 203–212. 21 indexed citations
20.
Weitz, Jeffrey I., Moira Cruickshank, Bob Thong, et al.. (1988). Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.. Journal of Clinical Investigation. 82(5). 1700–1707. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Weisel Breakdown of academic impact, for papers by RR Hantgan Breakdown of academic impact, for papers by Richard J. Travers Breakdown of academic impact, for papers by VJ Marder Breakdown of academic impact, for papers by Pierre F. Neuenschwander Breakdown of academic impact, for papers by David A. Meh Breakdown of academic impact, for papers by Reginald Tran Breakdown of academic impact, for papers by Kevin R. Siebenlist Breakdown of academic impact, for papers by Irina N. Chernysh Breakdown of academic impact, for papers by Gregory A. Hair
Rankless by CCL
2026